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http:WHAT THIS PAPER ADDS
This study demonstrates the safety and excellent long-term durability of surgical treatment for middle aortic
syndrome. Previous reports mostly dealt with congenital cases or stenosis in the thoracic aorta with little known
about stenosis in the abdominal aorta caused by inﬂammatory arteritis. This study provides the anatomic and
clinical characteristics, various operative methods for middle aortic syndrome caused by Takayasu arteritis, and
emphasizes the need for long-term follow up.Objective: Middle aortic syndrome (MAS) is a rare condition characterized by severe stenosis of the distal
thoracic or abdominal aorta. The aims of this study are to deﬁne the anatomic characteristics of MAS and to
review the various surgical methods and their outcomes in terms of long-term durability
Materials and methods: Ten adult patients were diagnosed with MAS caused by Takayasu arteritis (TA) or
midaortic dysplastic syndrome and underwent surgical treatment between July 1992 and January 2013.
Result: The aortic lesions were mostly suprarenal (n ¼ 7) and stenoses were commonly found in the celiac axis
(n ¼ 6), SMA (n ¼ 7), and renal artery (n ¼ 6). Indications for operation were uncontrolled hypertension in six
patients and lower extremity claudication in four. Eight aortic bypasses, one supraceliac aortic interposition graft,
and one bilateral aorto-renal bypass were performed. Adjunctive renal bypass with saphenous vein graft (n ¼ 4)
and IMA reimplantation (n ¼ 2) were performed simultaneously. There was no post-operative mortality, and one
complication of iliac dissection at the distal anastomosis site was detected and treated by stenting. Hypertension
was cured or improved in ﬁve of the six patients, and lower extremity claudication improved in all of them. With
a median follow up of 60 months (range, 12e263), all the aortic bypasses were patent and one adjunctive renal
artery bypass graft with aortic bypass was occluded 29 months post-operatively.
Conclusions: Aortic bypass for MAS is safe and shows excellent long-term durability. Considering the patients are
relatively young with a long life expectancy, aggressive surgical treatment could be beneﬁcial. Lifelong follow up
to monitor complications and disease progression is necessary.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Middle aortic syndrome (MAS) is a rare disease character-
ized by stenosis of the distal thoracic or abdominal aorta.1e3
The renal and visceral arteries are commonly involved in
MAS.4 The etiologies are diverse, including congenital
developmental anomaly, inﬂammatory aortitis, neuroﬁbro-
matosis, and Williams syndrome. Takayasu arteritis is one ofﬁrst two authors contributed equally to this work.
responding author. Department of Surgery, Seoul National Univer-
spital, 101 Daehak-ro, Jongno-gu, Seoul, 110e744, Republic of
il address: skminmd@snuh.org (S.-K. Min).
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//dx.doi.org/10.1016/j.ejvs.2015.04.032the most common causes of MAS in adults.5,6 The most
common symptoms of MAS are uncontrolled hypertension
or arterial insufﬁciency distal to the stenosis, including
lower extremity claudication.
There are several surgical treatment methods for MAS
including thoraco-abdominal bypass, interposition aortic
graft, and patch angioplasty. The general status and age of
the patients, the exact location and extent of aortic lesion,
and the existence of aortic branch disease should be
considered when selecting the surgical technique. Recently,
the outcomes of endovascular treatment, such as angio-
plasty or stenting, have been reported; however, long-term
results are still lacking.2,7,8
Coarctation of the thoracic aorta is well recognized;
however, little is known about stenosis in the abdominal
Table 1. Baseline patient and anatomic characteristics.
Baseline patient characteristics
Age at operation, years (median, range) 49 (23e59)
Age at diagnosis, years (median, range) 31 (8e50)
Sex (female) 8 (80%)
Clinical manifestations
Renovascular hypertension 6 (60%)
Combined renal insufﬁciency 2 (20%)
Lower extremity claudication 4 (40%)
Other vascular lesions
Surgical Treatment of Middle Aortic Syndrome 207aorta.5 In addition, most of the reports about MAS have
dealt with congenital cases in children. There are only a few
reports of MAS in adults with other etiologies.
Here 10 adult patients, who were diagnosed with MAS
mainly caused by Takayasu arteritis (TA) and underwent
surgical treatment, are presented. The aims of this study are
to deﬁne the anatomic characteristics of MAS and to review
the various surgical methods and their outcomes in terms of
long-term durability.Cardiovascular 4 (40%)
Carotid artery or subclavian artery 6 (60%)
Inﬂammatory markers
C-reactive protein, mg/dL (range) 0.12 (0.11e1.98)
Medical therapy at operation
Corticosteroid 1 (10%)
Immunosuppression 1 (10%)
Anatomic characteristics
Aortic disease
Suprarenal 7 (70%)
Interrenal 1 (10%)
Infrarenal 2 (20%)
Aortic branch disease
Renal artery 6 (60%)
Bilateral 4 (40%)
Unilateral 2 (20%)
Celiac axis 6 (60%)METHODS
Patients
Ten patients were diagnosed with MAS and underwent
surgical treatment between 1992 and 2012. MAS was
diagnosed by its characteristic radiological features: stenosis
or occlusion in the distal thoracic or abdominal aorta on
aortography or CT angiography. The clinical presentation,
pre-operative radiological ﬁndings, operative methods, and
follow up data were collected by a retrospective review of
the medical records. An earlier publication from 1995
included four patients in this series.9 This study was
approved by the institutional review board of the Seoul
National University Hospital.Pre-operative imaging
Pre-operative imaging of the aorta and aortic branches,
including the celiac axis, superior mesenteric artery (SMA),
inferior mesenteric artery (IMA), and renal arteries, was
done in all patients. Four patients from the earlier period of
this study were investigated by conventional catheter-based
aortography and recently all patients were examined with
multi-slice thin section CT angiography. The aortic lesions
were divided into three categories: suprarenal, interrenal,
and infrarenal stenoses. Stenosis above the celiac artery or
SMA is classiﬁed as “suprarenal,” stenosis below the SMA
and between the renal arteries as “interrenal,” and stenosis
below the renal artery as “infrarenal.”1Operative technique
A subcostal incision in the ninth interspace was made for
patients who required a thoraco-abdominal approach. A
midline transperitoneal approach was used for the patients
who underwent surgery for the abdominal aorta alone. The
preferred conduit was the knitted Dacron for aortic bypass
and autologous saphenous vein for renal bypass.Histologic examination
Pathological examination of the tissues obtained during the
operation was performed for ﬁve of the 10 patients. The
pathological criteria of TA included arterial wall inﬁltration
by lymphocytes, epithelioid cells or giant cells, destruction
of medial elastic ﬁbers, or replacement of medial smooth
muscle cells by ﬁbrosis.10Clinical outcomes
The major clinical manifestations were uncontrolled hyper-
tension and lower extremity claudication. In patients with
refractory hypertension, the outcomes of hypertension
control after the operation were classiﬁed as “cured” if the
patients were normotensive without taking antihypertensive
medication, “improved” if they were normotensive while on
one or two medications, and “failed” if they were still hy-
pertensive or required more than three medications. Im-
provements in claudication were assessed by symptoms and
the ankle brachial index (ABI). When stenoses in the renal
arteries were combined, the renal function was evaluated
with the estimated GFR, which was calculated by the modi-
ﬁcation of diet in renal disease (MDRD) study equation.Post-operative follow up
The patency of revascularization was assessed by angiog-
raphy in the earlier period of the study and by CT angiog-
raphy more recently. CT angiography was scheduled at 1, 6,
and 12 months after the operation and annually thereafter.
Blood pressure was measured at each visit, and ABI was
checked annually. All patients were treated with one or two
antiplatelet agents. Patients with active disease of inﬂam-
mation were treated with corticosteroid or immunosup-
pressive agents.Statistical analysis
Continuous data were summarized as the median with the
range, and categorical data were summarized as pro-
portions and percentages.
Figure 1. (A) Interrenal aortic coarctation. Pre-operative computed
tomographic angiography (CTA) showed severe stenosis of bilat-
eral renal arteries. (B) Bilateral retrograde aorto-renal bypass with
reversed saphenous vein graft was performed successfully.
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Patient characteristics
Eight female and two male patients were included. The
median age at diagnosis of MAS was 31 (range 8e50) years
and the median age at operation was 49 (range 23e59)
years (Table 1). In seven of the 10 patients, TA was
conﬁrmed according to the American College of Rheuma-
tology Diagnostic Criteria.11,12 In the remaining three pa-
tients, the diagnosis could not be conﬁrmed because they
did not match the criteria or show the characteristic ﬁnd-
ings in the tissue samples. These three cases were highly
indicative of sequelae of inﬂammatory vasculitis, and were
considered to be midaortic dysplastic syndrome.
Clinical manifestations
Uncontrolled hypertension was a major clinical manifesta-
tion in six patients, whose median pre-operative systolic
and diastolic blood pressure were 162 (range 132e190) and
87 (range 82e130) mmHg, respectively. All were treated
with more than four antihypertensive medications. Renal
insufﬁciency was combined in two patients, and their pre-
operative estimated GFRs were 16.1 and 17.0 mL/min/
1.73 m2, respectively. Four patients presented with symp-
toms of lower extremity claudication, and the median pre-
operative ABI was 0.49/0.44 (range, 0.45e1.08/0.44e1.08).
Four patients had cardiac lesions, one had aortic regurgi-
tation requiring valve replacement and three had conges-
tive heart failure. Six patients had subclavian or carotid
artery stenosis or occlusion. The median pre-operative C-
reactive protein level (CRP) was 0.12 mg/dL (range 0.11e
1.98). Two patients were treated with immunosuppressants,
such as prednisolone or methotrexate, at the time of the
operation.
Anatomic characteristics
The aortic lesion was suprarenal in eight patients (80%),
interrenal in one (10%), and infrarenal in one (10%). As for
aortic branch disease, renal artery stenosis was bilateral in
four patients (40%) and unilateral in two (20%). Celiac axis
stenosis or occlusion was found in six patients (60%) and a
superior mesentery artery (SMA) lesion was identiﬁed in
seven (70%).
Surgical techniques
An aorto-aortic bypass was performed in eight of 10 pa-
tients, with inﬂow from the distal thoracic aorta in ﬁve, the
supraceliac aorta in one, and the infrarenal aorta in two
patients. Knitted Dacron was used as the conduit in all
aortic bypasses. In four of eight patients, simultaneous
unilateral aorto-renal bypass with autologous saphenous
vein was performed. In two of eight patients, re-
implantation of the IMA to the aortic bypass graft was
required. Because of severe stenosis in the celiac axis and
SMA, abundant collaterals from the IMA supplied the small
bowel, and reimplantation of it was required. An interpo-
sition aortic-aortic graft with knitted Dacron was performedin one patient with segmental stenosis in supraceliac aorta.
Retrograde bilateral aorto-renal bypass with saphenous vein
grafts was performed in one patient with severe stenosis in
the both renal arteries (Fig. 1A,B).Operative outcomes
The median operative time was 337 minutes (range 220e
565). When the patients were divided according to the site
of inﬂow, the median operative time for the patients with
inﬂow from the descending thoracic aorta was 500 minutes
(range 220e595) and for patients with the abdominal aorta
214 minutes (range 285e250). The median length of hos-
pital stay was 12 days (range 8e23). There was no post-
operative mortality. One post-operative complication
occurred in a 31 year old female with lower extremity
claudication (Table 2, patient no. 8). Diffuse stenoses in the
abdominal aorta, celiac axis, and right renal artery, and
diffuse bilateral iliac hypoplasia were found on the pre-
operative CT angiography (Fig. 2A). The patient underwent
Surgical Treatment of Middle Aortic Syndrome 209bypass from the supraceliac aorta to the distal abdominal
aorta with a Dacron graft (Fig. 2B,C). She developed right
leg discomfort 5 days after the operation, and CT angiog-
raphy revealed bilateral common iliac artery dissection from
the distal anastomosis sites. She was treated by bilateral
common iliac artery stenting (Fig. 2D).
With a median follow up of 60 months (range 12e263),
all aortic bypass or interposition grafts were patent. One
adjunctive aorto-renal graft with saphenous vein occluded
and led to nephrectomy 29 months after the initial opera-
tion (Table 2, patient no. 4). No patient died during follow
up; however, two patients were lost to follow up at 45 and
60 months respectively. One patient had progressive dis-
ease requiring additional endovascular treatment. At ﬁrst,
she underwent an aortic bypass with a Dacron graft for
claudication and then required stenting of the right renal
artery because of hypertension 27 months after the initial
operation (Table 2, patient no. 8).Clinical outcomes
Hypertension was cured in two, improved in three, and
unchanged in one patient of the six with uncontrolled hy-
pertension. The median systolic and diastolic blood pres-
sures of all the patients at the last follow up were 117
(range 107e177) and 70 mmHg (range 54e82) respectively.
One patient with unchanged hypertension (Table 2, patient
no. 1) had diffuse stenosis in the abdominal aorta and left
renal artery and total occlusion of the right renal artery on
the pre-operative aortography. She underwent an aortic
bypass from the descending thoracic aorta to aortic bifur-
cation with an 18 mm Dacron graft and a left aorto-renal
bypass with a saphenous vein graft. Even though her
renal bypass graft remained patent, she still required four
types of antihypertensive medication: amlodipine,Table 2. Summary of patients, methods, and operative results.
No Age/
Sex
Clinical
manifestation
Aortic
lesion
Aortic branch
lesion
Name of opera
1 23/F Hypertension Suprarenal Celiac a., SMA,
renal a.
Aortic bypass (
bifurcation)
2 45/F Hypertension Suprarenal None Aortic interposi
3 49/M Hypertension Suprarenal SMA, Renal a. Aortic bypass (
bifurcation)
4 50/M Hypertension Suprarenal Renal a. Aortic bypass (
bifurcation)
5 59/F Claudication Infrarenal Celiac a., SMA Aortic bypass (
femoral a.)
6 54/F Claudication Suprarenal Celiac a., SMA Aortic bypass (
bifurcation)
7 56/F Hypertension Suprarenal Celiac a., SMA,
renal a.
Aortic bypass (
bifurcation)
8 33/F Claudication Suprarenal Celiac a., SMA,
renal a.
Aortic bypass (S
bifurcation)
9 49/F Hypertension Interrenal Celiac a., SMA,
renal a.
Aorto-renal byp
10 56/F Claudication Infrarenal None Aortic bypass (
Iliac a.)
DTA ¼ descending thoracic aorta; SMA ¼ superior mesentery artery.bisoprolol, candesartan, and hydralazine for blood pressure
control. All patients with symptoms of claudication experi-
enced complete relief of symptoms following bypass sur-
gery. The median post-operative ABI was 1.05/1.00 (range
0.92e1.08/0.92e1.08).DISCUSSION
Coarctation of the abdominal aorta is a rare disease caused
by many different etiologies: TA, ﬁbromuscular dysplasia,
and developmental anomaly.1 TA is chronic large vessel
granulomatous arteritis that affects the aorta and its major
branches.13 The current study focused on patients with TA
and excluded cases with developmental anomalies or
atherosclerosis. The symptoms of MAS were secondary
hypertension due to coarctation of the aorta, renal artery
stenosis or increased systemic resistance, and arterial
insufﬁciency in the lower extremities.14 Surgical treatment
is required to reduce the symptoms, to increase the quality
of life, and ultimately to increase life expectancy.
There are several studies reporting the surgical experi-
ence of MAS caused by TA10,13e18 (Table 3). Taketani et al.14
analyzed 33 patients with TA and reported that overall and
event-free survival rates at 20 years were 62.3% and 58.4%,
respectively. Field et al.10 showed that surgery for selected
patients was safe and had excellent long-term results;
however, patients with active disease were more likely to
require revision. Previous reports mainly dealt with pro-
gression of the disease or survival and included all of the
arterial areas. This study focused on abdominal aortic ste-
notic disease with many etiologies including Takayasu
arteritis, and analyzed the surgical methods and clinical
outcomes speciﬁcally.
Methods for aortic reconstruction include thoraco-
abdominal bypasses, interposition graft, and patchtion Concomitant
procedures
Graft patency Clinical
outcomes
FU
(mo)
DTA- Lt renal a.
bypass
Patent Failed 263
tion graft None Patent Cured 240
DTA- Lt renal a.
bypass
Patent Improved 214
DTA- Rt renal a.
bypass
Renal bypass
occlusion
Cured 45
Infrarenal- IMA
reimplantation
Patent Cured 60
DTA- IMA
reimplantation
Patent Cured 53
DTA- Lt renal a.
bypass
Patent Improved 68
upraceliac- None Patent Cured 54
ass None Patent Improved 23
Infrarenal- None Patent Cured 12
Figure 2. (A) Takayasu arteritis with claudication. Pre-operative CTA showed diffuse stenoses in the abdominal aorta, celiac axis, and right
renal artery, and diffuse bilateral iliac artery hypoplasia. (B) Abundant collaterals from the IMA due to the stenotic celiac axis and SMA. (C)
Bypass from the supraceliac aorta to the distal abdominal aorta with Dacron graft (D) Post-operative bilateral common iliac artery
dissection from the distal anastomosis site was found and treated by stenting.
210 S.M. Kim et al.aortoplasty. Endovascular therapy can be a treatment option
for MAS.7,13,19 Even though there have been many reports of
technically successful endovascular stenting for aortic
coarctation, reports of long-term results and clinical im-
provements are sparse. Destruction of the elastic ﬁbers in
media and ﬁbrosis of the adventitia could contribute to the
poor response of the vessels to angioplasty in TA patients.20
In addition, because of the high frequency of concomitant
aortic branch disease, suitable cases for endovascular treat-
ment are limited. In addition, the possibility of later con-
version to surgical treatment should be considered.
Considering that the patients are relatively young, long-term
durability is one of the most important things when selecting
the method of treatment. Therefore, the use of endovascular
therapy should be prudent and reserved for patients with a
focal aortic stenotic lesion or with high peri-operative risk.
There were neither post-operative deaths nor major
complications in this series. The most common complication
after surgery was cardiovascular or cerebrovascular disease
associated with TA. No patient experienced stroke or heart
failure peri-operatively. Even though aortic bypass in TA
patients seems to be an aggressive procedure, it can be
performed safely with a thorough pre-operative evaluation
and proper patient selection. There was a report that stroke
accounted for 9.5% of deaths in TA patients.16 Miyata
et al.17 reported that the most common cause of death was
congestive heart failure and the overall survival rate at 20
years after surgical treatment was 73.5%. A median follow
up of 60 months is relatively short to determine late com-
plications or death. Therefore, consistent follow up of these
patients is required in terms of cardiovascular or cerebro-
vascular disease.
Dissection in the iliac arteries after clamping occurred in
one patient. Fortunately, the dissection was found early and
treated successfully by stenting. Thickened intima and
ﬁbrotic adventitia in TA patients can be the cause of arterial
dissection. Another common surgical complication is anas-
tomotic aneurysm. Destruction of the elastic component ofthe media, which occurs before ﬁbrosis of the adventitia,
can weaken the vessel wall and cause aneurysm.21 Ac-
cording to a previous report, the incidence of anastomotic
aneurysm was 13.8% at 20 years.17 Another study reported
the cumulative incidence of anastomotic aneurysm of
12.2% at 10 years, 21.2% at 20 years, and 37.3% at 30
years.14 Most were detected incidentally without any
symptoms or signs, and devastating results can happen
unexpectedly. In a recent multicenter study with 166
vascular procedures in TA patients, the overall 5 and 10 year
arterial complication free survival rates were only 56% and
45%, respectively.18 In a series with 40 patients with TA,
progression or recurrence of disease occurred in 40% of the
patients over a mean follow up of 6.4 years.15 Therefore,
even though the present results look favorable with no
anastomotic aneurysms, regular follow up using imaging
modalities for arterial complications are necessary.
There was a patient who had sustained hypertension
even after the operation. The 23 year old patient had had
renovascular hypertension for 15 years and underwent
aortic bypass with left renal artery bypass. She continued
treatment with four kinds of antihypertensive medications,
even though the bypass grafts were patent. Renal artery
stenosis is a signiﬁcant cause of hypertension in TA patients;
however, hypertension occurs in 5e30% patients in the
absence of renal artery stenosis.21 Aortic coarctation,
reduced aortic compliance, and dysfunction of the carotid
baroreceptor could be the causes of hypertension in these
patients. In the case of long-lasting renovascular hyper-
tension or renal artery thrombosis, fundamental loss of
renal parenchyma occurred and revascularization could not
improve the clinical ﬁndings. Thorough evaluation of the
arterial system and determination of which blood vessel is
the main cause of the hypertension are required.
Aortic bypass or interposition was performed with the
trans-abdominal approach without thoracotomy in four
patients. Of these, two patients had a suprarenal lesion.
Even though the aortic stenoses were diffusely involved
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Surgical Treatment of Middle Aortic Syndrome 211from the supraceliac or suprarenal aorta, proximal control
on the thoracic aorta is not always necessary. If there is
enough space for aortic clamping and anastomosis to the
non-diseased aorta, a trans-abdominal approach with
medial visceral rotation could be an option to reduce the
operative time and complications which follow thoracot-
omy. The patients with the trans-abdominal approach were
followed up for 240 and 54 months after the operation
respectively, and there was no problem at the anastomosis
site or progression of aortic stenosis.
In this series, only two of the 10 patients were treated
with steroids or immunosuppression: one with predniso-
lone (5 mg once a day) and methotrexate (7.5 mg once a
week), and the other with prednisolone (10 mg once a day).
Both patients have stable disease with normal CRP and ESR
level. The patients who were referred to vascular surgeons
were usually in a chronic state and on steroid therapy
during the acute phase. It is recommended that revascu-
larization procedures should not be performed during the
active phase of the disease.22 However, a uniform marker
for disease activity is lacking and the serum marker does not
always correlate with the inﬂammatory activity in the vessel
wall.10 Disease activity was assessed by combining clinical
information, biomarkers, and image modalities.
Whether steroids or immunosuppression can prevent
disease progression or recurrence after revascularization
has been controversial. There were studies that showed
freedom free revision, recurrence, or disease progression
were not different between groups whether taking long-
term steroids or not.10,15 Park et al.,23 however, reported
a lower restenosis rate with post-interventional immuno-
suppressive treatment. In contrast with the conﬂicting re-
sults for immunosuppression, antiplatelet agents are
recommended to prevent arterial ischemic events in TA
patients.24
There are several limitations of this study. First, it is a
retrospective case series with a small number of patients.
Second, it reported the results of surgical bypass only and
did not show comparative data with endovascular treat-
ment. It is necessary to deﬁne the indications, technical
aspects, and long-term outcomes of endovascular treat-
ment in further studies.CONCLUSION
MAS caused by TA or midaortic dysplastic syndrome pre-
sented in various locations of the aorta and was mostly
combined with stenosis in the celiac axis, SMA, and renal
arteries. Aortic bypass with concomitant renal bypass is safe
and shows excellent long-term durability. Considering the
patients are relatively young with long life expectancy,
surgical treatment may be beneﬁcial. Lifelong follow up is
necessary to monitor for complications and disease
progression.CONFLICT OF INTEREST
None.
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